A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults

Study Identifier:
ACH471-014
ClinicalTrials.gov Identifier:
NCT05109390
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: Danicopan
  • Drug: Cyclosporine
  • Drug: Tacrolimus
  • Drug: Calcium Carbonate
  • Drug: Aluminum/Magnesium Hydroxide/Simethicone
  • Drug: Omeprazole
Date
Jul 2018 - Oct 2018
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 55 Years
Requirements Information
Sex
Female & Male
Age
18 - 55 Years

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: Danicopan
  • Drug: Cyclosporine
  • Drug: Tacrolimus
  • Drug: Calcium Carbonate
  • Drug: Aluminum/Magnesium Hydroxide/Simethicone
  • Drug: Omeprazole
Date
Jul 2018 - Oct 2018
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 55 Years years
Requirements Information

Protocol Summary

This was a 3-part study with each part being an open-label, fixed-sequence, 2-period study in healthy adult participants.

Trial Locations

Location
Status
Location
Clinical Trial Site
Tempe, Arizona, United States, 85283
Status
N/A